Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022010937 - ADVANTAGEOUS BENZOTHIOPHENE COMPOSITIONS FOR MENTAL DISORDERS OR ENHANCEMENT

Publication Number WO/2022/010937
Publication Date 13.01.2022
International Application No. PCT/US2021/040570
International Filing Date 06.07.2021
IPC
A61K 31/496 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
C07D 409/12 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
409Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
C07D 409/14 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
409Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
14containing three or more hetero rings
Applicants
  • TACTOGEN INC [US]/[US]
Inventors
  • BAGGOTT, Mathew
Agents
  • BELLOWS, Brent, R.
  • KNOWLES, Sherry, M.
  • PROSSER, Anthony, R.
  • STRONG, Katie, L.
Priority Data
63/048,64006.07.2020US
63/069,13523.08.2020US
63/149,20812.02.2021US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) ADVANTAGEOUS BENZOTHIOPHENE COMPOSITIONS FOR MENTAL DISORDERS OR ENHANCEMENT
(FR) COMPOSITIONS DE BENZOTHIOPHÈNE AVANTAGEUSES POUR TROUBLES MENTAUX OU AMÉLIORATION MENTALE
Abstract
(EN) Pharmaceutically active benzothiophene compounds and their pharmaceutically acceptable salts and salt mixtures and pharmaceutically acceptable compositions for the treatment of mental disorders or for mental enhancement, including for entactogenic therapy, and generally for modulating central nervous system activity.
(FR) L'invention concerne des composés de benzothiophène pharmaceutiquement actifs et leurs sels et mélanges de sels pharmaceutiquement acceptables et des compositions pharmaceutiquement acceptables pour le traitement de troubles mentaux ou pour l'amélioration mentale, y compris pour une thérapie par entactogène, et globalement pour moduler l'activité du système nerveux central.
Latest bibliographic data on file with the International Bureau